Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 5
R&D Momentum
71/100
Pipeline Velocity
43/100
Trial Completion Rate
64/100
Pipeline Concentration
31/100
Pipeline Freshness
38/100
Strategic Signals
Activity
Last 14 days
Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure (OSPREY-AHF)
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans (EGGS)
Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
Severe Asthma Research Program
Phase II Study of CC-5013 in Patients With Advanced Renal Cell Carcinoma (RCC)
Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training
Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal Crohn's Disease: A Phase II Randomized Trial
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)